HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 361-372 of 1,979
Drug study icon
CompletedNCT01552837

Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in people with Bipolarity: Searching for Antidepressant and Mood Stabilising Neurophysiology

Official study title

Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology

This study has finished and is no longer accepting participants.

In Aachen
BipolarityMedication studyAges 18–55
Countries
Germany
Sponsor
RWTH Aachen University
Drug study icon
CompletedNCT01244815

Asenapine Treatment for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of asenapine for people with bipolarity.

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 10–17
Countries
Sponsor
Organon and Co
Drug study icon
CompletedNCT00741598

Galantamine for Bipolarity

What is this study about?

Researchers compared Galantamine-ER and placebo, tracking side effects to assess safety in people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Boston
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Drug study icon
CompletedNCT00266630

Olanzapine for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of olanzapine for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Akita
BipolarityMedication studyAges 20–65
Countries
Japan
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT00254774

Quetiapine Compared With Valproate for Bipolarity

Official study title

Pilot Study of the Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling: an Open Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Berlin
BipolarityMedication studyAges 18–65
Countries
Germany
Sponsor
AstraZeneca
Drug study icon
CompletedNCT00114686

Quetiapine Fumarate (SEROQUEL®) for Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Quetiapine fumarate for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
BipolarityMedication studyAges 21–60
Countries
United States
Sponsor
AstraZeneca
Drug study icon
CompletedNCT00081380

Seroquel Plus Mood Stabilizer for Bipolarity

Official study title

Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityMedication studyAges 18+
Countries
United States, Canada
Sponsor
AstraZeneca

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.